ZRC-NB-3224

N/A

Report date: 2024/11/14 16:49:46

Base Information

Drug NameZRC-NB-3224
Drug Alias NameZRC-NB-3224
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionProperdin inhibitors
TargetsProperdin
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZydus Cadila
China Registration ClassN/A

Develop Information

Active CompaniesZydus Cadila
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A